Skip to content

Feasibility, Safety, and Efficacy of Transcutaneous Electrical Acupoint Stimulation Combined With Different Doses of Polyethylene Glycol Electrolyte Powder for Bowel Preparation Before Colonoscopy: A Two-Center, Exploratory, Randomized Controlled Trial

Feasibility, Safety, and Efficacy of Transcutaneous Electrical Acupoint Stimulation Combined With Different Doses of Polyethylene Glycol Electrolyte Powder for Bowel Preparation Before Colonoscopy: A Two-Center, Exploratory, Randomized Controlled Trial

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600125452
Enrollment
Unknown
Registered
2026-05-27
Start date
2026-06-01
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bowel preparation

Interventions

2L PEG+TEAS group:The TEAS intervention was administered for 60 minutes, starting 2 to 4 hours before the first dose of PEG, followed by oral administration of PEG.
3L PEG group:Received a standard 3L polyethylene glycol (PEG) bowel preparation.
3L PEG+TEAS group:TEAS intervention was administered for 60 minutes, starting 2–4 hours before the first dose of PEG, followed by oral intake of PEG.

Sponsors

Hangzhou First People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Scheduled to undergo screening, surveillance, or diagnostic colonoscopy as an inpatient; 2. Adult patients aged 18 to 75 years, regardless of sex; 3. Provide written informed consent;

Exclusion criteria

Exclusion criteria: 1. Speech or cognitive impairment; 2. Impaired skin sensation or ulceration at the stimulation site; 3. Severe cardiopulmonary insufficiency, renal failure, or history of stroke or myocardial infarction within the past 6 months; 4. History of abdominal or pelvic surgery; 5. Pregnant or lactating women; 6. Inflammatory bowel disease, watery stools within the past week, or presence of alarm symptoms or signs for colorectal cancer; 7. Implanted pacemaker, internal metal plates/screws, or mechanical ventilation;

Design outcomes

Primary

MeasureTime frame
Pass rate of bowel preparation;

Secondary

MeasureTime frame
Adverse Events, Patient Satisfaction, Tolerability, and Adherence During Bowel Preparation;Adenoma Detection Rate, Polyp Detection Rate;

Countries

China

Contacts

Public ContactYe Xiangsheng

Hangzhou First People's Hospital

yxshhzsy@126.com+86 135 1587 6528

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 11, 2026